期刊文献+

早发型与晚发型帕金森病多巴胺能神经元和脑葡萄糖代谢变化差异 被引量:1

Differences of dopamine neurons and brain glucose metabolism between early-onset and late-onset Parkinson's disease
下载PDF
导出
摘要 目的观察早发型帕金森病(EOPD)与晚发型帕金森病(LOPD)多巴胺神经元和脑葡萄糖代谢变化差异。方法前瞻性纳入45例EOPD患者(EOPD组)、55例LOPD患者(LOPD组)及93名健康对照(HC)者[HC1组(n=47),HC2组(n=46)],行^(11)C-β-CFT和18 F-FDG PET显像;观察EOPD组与HC1组、LOPD组与HC2组脑^(11)C-β-CFT标准摄取值比值(SUVR)和18 F-FDG葡萄糖代谢网络模式,以回归分析评估脑区^(11)C-β-CFT SUVR与18 F-FDG葡萄糖代谢的关系。结果EOPD组与HC1组之间,尾状核、壳核和苍白球^(11)C-β-CFT SUVR差异均有统计学意义(P均<0.05);LOPD组与HC2组之间,伏隔核、尾状核、壳核和苍白球^(11)C-β-CFT SUVR差异均有统计学意义(P均<0.05)。与HC1组相比,EOPD组双侧尾状核、壳核、苍白球、岛叶、小脑、颞叶、丘脑及额叶葡萄糖代谢明显增高(P均<0.05);相比HC2组,LOPD组双侧壳核、苍白球、中央旁回、小脑、颞叶及丘脑葡萄糖代谢明显增高(P均<0.05),双侧尾状核和额叶葡萄糖代谢明显减低(P均<0.05)。尾状核代谢为EOPD组伏隔核^(11)C-β-CFT SUVR减低的影响因素(P<0.001);尾状核、前额叶、小脑及丘脑代谢均为LOPD组伏隔核^(11)C-β-CFT SUVR减低的影响因素(P均<0.001)。结论LOPD患者伏隔核多巴胺神经元受损、尾状核和额叶葡萄糖代谢明显减低,而EOPD患者未见上述表现。 Objective To observe the differences of dopamine neurons and brain glucose metabolism between early-onset Parkinson's disease(EOPD)and late-onset Parkinson's disease(LOPD).Methods Forty-five EOPD patients(EOPD group),55 LOPD patients(LOPD group)and 93 healthy controls(HC)(HC1 group[n=47],HC2 group[n=46])were prospectively enrolled.^(11)C-β-CFT and 18 F-FDG PET imaging were performed.The standard uptake value ratio(SUVR)and 18 F-FDG glucose metabolic network pattern of brain were compared between EOPD group and HC1 group,also between LOPD group and HC2 group.Regression analysis was used to evaluate the relationships of ^(11)C-β-CFT SUVR and 18 F-FDG glucose metabolism of brain.Results Significant differences of ^(11)C-β-CFT SUVR in caudate nucleus,putamen and globus pallidus were found between EOPD group and HC1 group(all P<0.05),also among nucleus accumbens,caudate nucleus,putamen and globus pallidus between LOPD group and HC2 group(all P<0.05).Glucose metabolism in bilateral caudate nucleus,putamen,globus pallidus,insula,cerebellum,temporal lobe,thalamus and frontal lobe in EOPD group were significantly higher than those in HC1 group(all P<0.05).Glucose metabolism in bilateral putamen,globus pallidus,paracentral gyrus,cerebellum,temporal lobe and thalamus in LOPD group were significantly higher(all P<0.05),while in bilateral caudate nucleus and frontal lobe were significantly lower than those in HC2 group(both P<0.05).Glucose metabolism in caudate nucleus was the impact factor of decreased ^(11)C-β-CFT SUVR in nucleus accumbens of EOPD group(P<0.001),while glucose metabolism in caudate nucleus,prefrontal lobe,cerebellum and thalamus were all the impact factors of decreased ^(11)C-β-CFT SUVR in nucleus accumbens of LOPD group(all P<0.001).Conclusion Dopamine neurons in nucleus accumbens were damaged in LOPD patients with significantly decreased glucose metabolism in caudate nucleus and frontal lobe,which did not occur in EOPD patients.
作者 常燕 张熙琬 王媛 刘家金 赵东 付华平 张锦明 单保慈 刘若卓 王瑞民 CHANG Yan;ZHANG Xiwan;WANG Yuan;LIU Jiajin;ZHAO Dong;FU Huaping;ZHANG Jinming;SHAN Baoci;LIU Ruozhuo;WANG Ruimin(Graduate School,Chinese PLA Medical School,Beijing 100853,China;Department of Neurology,Chinese PLA General Hospital,Beijing 100853,China;School of Physics,Zhengzhou University,Zhengzhou 450001,China;School of Nuclear Science and Technology,University of Chinese Academy of Sciences,Beijing 100049,China;Department of Nuclear Medicine,the First Medical Centre,Chinese PLA General Hospital,Beijing 100853,China;Beijing Engineering Research Center of Radiographic Techniques and Equipment,Institute of High Energy Physics,Chinese Academy of Sciences,Beijing 100049,China)
出处 《中国医学影像技术》 CSCD 北大核心 2023年第10期1445-1449,共5页 Chinese Journal of Medical Imaging Technology
基金 国家自然科学基金(11975249) 北京市卫生健康委员会住院医师规范化培训质量提高项目 军队后勤保健专项(23BJZ21)。
关键词 帕金森病 多巴胺 F18氟脱氧葡萄糖 正电子发射断层显像 Parkinson disease dopamine fluorodeoxyglucose F18 positron-emission tomography
  • 相关文献

参考文献1

二级参考文献11

  • 1Zouzeilles MI, Merello M. Correlation between results of motor section of UPDRS and Webster Scale[J]. Mov Disotd. 1997,12:613.
  • 2Patrick SK, Denington AA, Gauthier M J, et al. Quantification of the UPDRS Rigidity, Scale. IEEE Trans Neural Syst[J]. Rehabil Eng, 2001,9:31-41.
  • 3Tison F, Yekhief F, Chrysostome V, et al. Parkinsonism in multiple system atrophy: natural history, severity ( UPDRS-Ⅲ), and disability assessment compared with Parkinson's disease[J]. Mov Disord,2002; 17:701-709.
  • 4Brooks DJ. Monitoring neuroprotectian and restorative theraies in Parkinson's disease with PET[J] .J Neural Transtn, 2000(Suppl), 125-137.
  • 5Brucke T, Djamshidian S, Bencsits G, et al. SPECT and PET imaging of the dopaminergic system in Parkinson ' s disease[ J ]. J Neurol, 2000,247 ( Suppl4) :2-7.
  • 6Kazunmta K, Dhawan V, Chaly T, et al. Dopamine transporter imaging with fluorine-18-EPCIT mad PET[J] .J Nucl Med, 1998,39:1521-1530.
  • 7Rinne JO, Ruotlinen H, Bergnmn J, el al. Usefulness of a dopamine transporter PET ligand [(18) F] bela-CFT in assessing disability in Parkinson ' s disease[ J ]. J Neurol Neurosurg Psychiatry, 1999,67 : 737-741.
  • 8Nurmi E, Ruottinen HM, Bergman J, et al. Rate of progression in Parkinso's disease:a 6-[ 18F]fluoro-L-dopa PET study[J]. Mov Disord,2001,16:608-815.
  • 9Bhatia K, Marsden C. The behavioral and motor consequences of focal lesions of the basal ganglia in man[J]. Brain, 1994,117:859-876.
  • 10陈海波 王新德.统一帕金森病评定量表[J].中华老年医学杂志,1999,18(1):61-62.

共引文献9

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部